Analysis of the assortment of antidiabetic drugs at the pharmaceutical market of Ukraine

O. V. Trygubchak

Abstract


 

The marketing research of antidiabetic drugs presented at the pharmaceutical market of Ukraine has been conducted. The product range of the group of antidiabetic drugs has been studied according to the ATC classification, manufacturing countries and dosage forms. According to the results of the analysis 49 drugs based on insulin and its analogues for injection, and 157 oral hypoglycemic drugs have been characterized. It is noted that insulins are unevenly divided by the duration of action. Most insulin drugs are presented by human insulin. Oral hypoglycemic drugs are characterized by a high saturation within subgroups. Drugs of aldose reductase inhibitors (Isodibut under the trade name Isodibut®) and other medicines, including 8 herbal medicines, are also used for treatment of diabetes. It has been found that 68% of antidiabetic drugs are imported from 21 countries of the Eurasian and South American continents. India occupies the leading positions. A wide range of antidiabetic drugs is presented by Germany, Poland, France, Denmark and Italy. The range of domestic drugs for treating diabetes is formed by 12 manufacturers. Domestic manufacturers offer only generic replacement of some active substances. At the pharmaceutical market of Ukraine antidiabetic drugs are available in the form of tablets, granules, powders, solutions and suspensions for injection. The research performed has shown that the market of antidiabetic drugs is characterized by heterogeneity of product groups, high concentration and monopolization of production, low competition and a small share of production of drugs attributable to domestic producers.



Keywords


diabetes; drugs; assortment; marketing research; pharmaceutical market

Full Text:

PDF

References


Державний реєстр лікарських засобів України – [Електронний ресурс]. – Режим доступу: http://www.drlz.kiev.ua. – Назва з екрану.

Кирсанов Д. // Еженедельник «Аптека». – 2013. – № 50 (921). – С. 18-19.

Компендиум 2011– лекарственные препараты / Под ред. В.Н.Коваленко, А. П. Викторова. – К.: Морион, 2011. – 2320 с.

Ларін О. С. // Міжнародний ендокринологічний журнал. – 2011. – № 3 (35). – С. 10-19.

Паньків В.І. // Международный эндокринологический журнал. – 2013. – № 7 (55). – С. 95-104.

Beagley J., Guariguata L., Weil C. et al // Diabetes Res Clin Pract – 2014. – Vol. 103, Issue 2. – P. 150-160.

Conway B.N., May M.E., Fischl A. et al // Diabet Med. – 2015. – Vol. 32(1). – P. 33-41.

Blackwell Publishing Ltd // Diabet Med. – 2010. – Vol. 27. – Р. 318-326.

Danaei G., Finucane M.M., Lu Y. et al. // Lancet, 2011. – 378 (9785) – P. 31-40.

Frandsen C.S., Madsbad S. // Diabet Med. – 2014. – Vol. 31(11). – P. 1293-1300.

Global status report on noncommunicable diseases 2010. / Editor Ala Alwan. – Geneva: World Health Organization, 2011. – 176 p.

IDF. Diabetes atlasidf diabetes atlas. Sixth edition // International Diabetes Federation – 2013. – 160 p.

Mathers C.D., Loncar D. // PLoS Med. – 2006. – Vol. 3 (11). – Р. 442.

Moses R.G., Bartley P., Lunt H. et al // Diabetic Med. – 2009. – Vol. 26, Issue 3. – P. 260-267.

Turner K.M., Percival J., Dunger D.B. et al // Diabet Med. – 2015. – Vol. 32(2). – Р. 250-256.


GOST Style Citations






DOI: https://doi.org/10.24959/88906

Abbreviated key title: Vìsn. farm.

ISSN 2415-8844 (Online), ISSN 1562-7241 (Print)